Evelyn Partners Investment Management LLP

Position in ALNY — Alnylam Pharmaceuticals, Inc.

CIK 2065206 London, X0

Position in ALNY

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$57,902

-$11,686 QoQ

Shares Held

175

0.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2024

6 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

Evelyn Partners Investment Management LLP holds $149,476 across 6 Biotechnology names. ALNY ranks #2 (38.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	CRSP	CRISPR Therapeutics AG	1,300	$61,841
2	ALNY	Alnylam Pharmaceuticals, Inc. This page	175	$57,902
3	ARVN	Arvinas, Inc.	1,474	$15,624
4	ONC	BeOne Medicines Ltd.	41	$12,175
5	PRTA	Prothena Corp Public Ltd Co	199	$1,934
6			150	$0

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$57,902	175	0.0%	Shares	Sole	2026-05-15
2025-12-31	$69,588	175	0.0%	Shares	Sole	2026-02-13
2025-09-30	$79,800	175	-30.0%	Shares	Sole	2025-11-14
2025-06-30	$81,522	250	0.0%	Shares	Sole	2025-11-26
2025-03-31	$67,505	250	0.0%	Shares	Sole	2025-12-08
2024-12-31	$58,827	250	—	Shares	Sole	2025-12-11
No filing history on record for this holder in this stock.